Effects of Tocilizumab in COVID-19 patients: a cohort study

Authors: Christine A. Vu, Kailynn J. DeRonde, Ana D. Vega, Meshell Maxam, Gregory Holt, Yoichiro Natori, Jose Gonzales Zamora, Veronica Salazar, Renata Boatwright, Stephen R. Morris, Daniela de Lima Corvino, Anmary Fernandez Betances, Leah Colucci, James Keegan, Andy Lopez, Andrew Hany Rezk, Yvette Rodriguez, Gabriela M. Moraru, Susanne Doblecki, David J. De La Zerda, Lilian M. Abbo

Source: BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)

Subject Terms: Coronavirus, COVID-19, Tocilizumab, Cytokine release syndrome, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2334

Access URL: https://doaj.org/article/4df1660067b9456fa0d9d27a036408b6